Full access
APA Institute
Published Online: 1 August 2003

Drug-Company Marketing Tactics Grist for Institute Debate on Ethics

Charles Huffine, M.D.Authors Info & Affiliations
Publication: Psychiatric News
Volume 38, Number 15
https://doi.org/10.1176/pn.38.15.0023a
The role of pharmaceutical companies in psychiatry is being hotly debated within our profession. No issue raises more passion than that of the propriety of these companies attempting to influence our clinical decision making. Also of concern is the perception of those outside the profession of psychiatry that drug companies can influence psychiatrists with presents, dinners, and free samples.
This issue appears frequently on the American Association of Community Psychiatrists (AACP) list serve. Lately, the discussions have had a degree of intensity that seems to mirror the growing ambivalence regarding pharmaceutical companies.
In an effort to bring some depth and wisdom to that discussion, the Scientific Program Committee of APA’s Institute on Psychiatric Services offers the debate “Resolved: It Is Unethical for Psychiatrists to Invite Sales Representatives to Market Products Through Such Methods as Educational Materials, Samples, and Gifts in Clinical Settings.”
The participants in this debate are, on the affirmative, Charles Goldman, M.D., director of public psychiatry training in the department of neuropsychiatry and behavioral sciences at the University of South Carolina; and, on the negative, Michael Silver, M.D., of the Providence Center and a member of the clinical faculty at Brown University in Rhode Island and a former AACP president. David Moltz, M.D., co-chair of the AACP’s Ethics Committee, will be the moderator.
Both Drs. Goldman and Silver are thoughtful leaders in community psychiatry and are passionate about ethical issues in our profession. It will be a treat hearing this affect-filled subject dealt with by two such wise and gracious colleagues. ▪

Footnote

Dr. Huffine is a member of the Scientific Program Committee of the 2003 Institute on Psychiatric Services.

Information & Authors

Information

Published In

Go to Psychiatric News
Psychiatric News
Volume 38 • Number 15 • August 1, 2003
Pages: 23

History

Published online: 1 August 2003
Published in print: August 1, 2003

Notes

Does pharmaceutical marketing influence physicians’ clinical decisions? Or are physicians informed practitioners quite capable of making objective decisions?

Authors

Affiliations

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard
Tips for downloading citations

There are no citations for this item

View Options

View options

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share

×

As described within the American Psychiatric Association (APA)'s Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences. Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.